NR-566 Midterm Exam 2026/2027 Questions & Answers: Antibiotics, Antifungals, Antivirals, Antiparasitics, Allergy & Glaucoma | Chamberlain University

This comprehensive NR-566 Midterm Exam 2026/2027 study guide contains a large collection of exam-style questions and answers across 36 pages, focusing on antimicrobial and infectious-disease pharmacology, allergy and respiratory medications, glucocorticoids, and ophthalmic pharmacology. The material begins with core antimicrobial principles, including narrow- versus broad-spectrum antibiotics, bactericidal versus bacteriostatic agents, antimicrobial resistance mechanisms, empiric therapy, antibiotic stewardship, culture-directed therapy, and antibiotic considerations during pregnancy and childhood. NR566 Midterm 2026 A substantial portion covers antibacterial pharmacology and major drug classes. Students review penicillins and other beta-lactams, cephalosporins, carbapenems, monobactams, vancomycin, tetracyclines, macrolides, clindamycin, linezolid, aminoglycosides, and sulfonamides. High-yield concepts include mechanisms of action, bactericidal versus bacteriostatic activity, renal dosing, penicillin allergy and cephalosporin cross-sensitivity, beta-lactamase, MRSA and VRE therapy, C. difficile, red man syndrome, QT prolongation, Stevens-Johnson syndrome, nephrotoxicity, ototoxicity, peak and trough monitoring, CYP3A4 interactions, and clinically important interactions with warfarin, digoxin, valproate, SSRIs, and other medications. NR566 Midterm 2026 The document connects pharmacology with common infections and organisms, including community-acquired pneumonia, Streptococcus pneumoniae, E. coli urinary tract infections, H. pylori, MRSA, C. difficile, rickettsial disease, chlamydial infections, Lyme disease, and uncomplicated UTIs. It also addresses antibiotic use across the lifespan, including tetracycline-associated tooth discoloration, sulfonamide-associated kernicterus, aminoglycoside toxicity, pregnancy contraindications, breastfeeding considerations, and antimicrobial patient education. NR566 Midterm 2026 The antifungal and antiviral sections review amphotericin B, azole antifungals, griseofulvin, fluconazole, nystatin, terbinafine, itraconazole, acyclovir, valacyclovir, ganciclovir, lamivudine, tenofovir, interferons, ribavirin, cidofovir, and foscarnet. Conditions covered include tinea corporis, tinea cruris, tinea capitis, tinea pedis, vulvovaginal candidiasis, oral candidiasis, onychomycosis, HSV, VZV/herpes zoster, CMV, and hepatitis A, B, and C. The guide emphasizes mechanisms, adverse effects, boxed warnings, renal and hepatic monitoring, pregnancy considerations, and clinically significant electrolyte abnormalities. NR566 Midterm 2026 Additional infectious-disease pharmacology covers influenza vaccination and oseltamivir, HIV antiretroviral therapy, NRTI adverse effects, and antiparasitic/antihelminthic medications. The parasitology material includes ivermectin, moxidectin, praziquantel, albendazole, mebendazole, and pyrantel pamoate, together with roundworm, pinworm, hookworm, whipworm, threadworm, helminthiasis, anemia associated with hookworm, and the Mazzotti reaction. Monitoring concepts include pregnancy testing, CBC, liver-function testing, blood-pressure monitoring, and special considerations during breastfeeding. NR566 Midterm 2026 The final sections expand into H1 antihistamines, glucocorticoids, allergic rhinitis, cough and cold medications, and glaucoma pharmacotherapy. Topics include antihistamine adverse effects and Beers Criteria considerations, promethazine safety, long-term glucocorticoid complications, baseline monitoring, intranasal corticosteroids, cromolyn, pseudoephedrine and other sympathomimetics, rebound congestion, codeine, dextromethorphan, and benzonatate. Ophthalmic content covers open- and angle-closure glaucoma concepts, beta-blocker eye drops, prostaglandin analogs such as latanoprost, brimonidine/Alphagan, intraocular-pressure monitoring, Restasis, keratolytic agents, and salicylism. NR566 Midterm 2026 Relevant students: This document is particularly relevant to NR-566 students, Family Nurse Practitioner (FNP) students, Adult-Gerontology Nurse Practitioner students, MSN and DNP students, advanced-practice nursing students, and nurse practitioner students studying infectious-disease and antimicrobial pharmacology. It is especially useful for learners reviewing drug mechanisms, antimicrobial selection, adverse effects, medication interactions, pregnancy and pediatric considerations, laboratory monitoring, patient education, antifungal and antiviral therapy, allergy medications, and ophthalmic pharmacology. Keywords: NR 566 midterm exam, NR566 midterm , NR 566 questions and answers, NR566 midterm study guide, Chamberlain University NR 566, advanced pharmacology midterm, FNP pharmacology exam, antimicrobial pharmacology, antibiotic pharmacology, antibiotic stewardship, broad spectrum antibiotics, narrow spectrum antibiotics, bactericidal antibiotics, bacteriostatic antibiotics, penicillin pharmacology, beta lactam antibiotics, cephalosporins, carbapenems, vancomycin, MRSA treatment, C difficile treatment, tetracyclines, macrolides, clindamycin, linezolid, aminoglycosides, sulfonamides, antifungal medications, amphotericin B, azole antifungals, antiviral pharmacology, acyclovir, hepatitis medications, CMV treatment, influenza pharmacology, HIV medications, antiparasitic medications, antihelminthic drugs, antihistamines, glucocorticoids, allergic rhinitis medications, cough medications, glaucoma medications, latanoprost, advanced practice nursing pharmacology